Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Products
  • Duloxetine Delayed-Release Capsules USP
Where it was sold

Nationwide.

Nationwide

Units affected
209,376 bottles
About this recall
Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ NDC 57237-017-60